R. Milroy (Glasgow, United Kingdom), A. Rozman (Golnik, Slovenia), D. Misch (Berlin, Germany), A. Fisseler-Eckhoff (Wiesbaden, Germany)
Octogenarians with non-small cell lung carcinoma – Advanced disease L. Fernandes, C. Santos, I. Sanches, A. Figueiredo, F. Barata (Coimbra, Portugal)
| |
The primitive bronchogenic carcinoma in the elderly H. Benjelloun, N. Zaghba, N. Yassine, A. Bakhatar, A. Bahlaoui (Casablanca, Morocco)
| |
Impact of radon residential concentration in the development of lung cancer in Transilvania, Romania L.E. Rosca, D.A. Todea (Cluj Napoca, Romania)
| |
LATE-BREAKING ABSTRACT: Seroprevalence of human herpesvirus type 8 infection in patients with lung carcinoma S. M. Tsao, C. L. Lai, M. N. Lin, C. C. Su (Taichung, Chiayi, Taiwan)
| |
Pulmonary function testing in patients with lung cancer R. Melchor Iñiguez, M.J. Rodríguez Guzmán, A. Martín de San Pablo Sánchez, M.B. Gallegos Carrera, S. Cordova Yamauchi, M.J. Fernández Aceñero (Madrid, Spain)
| |
Rate of chest x-rays (CXR) 12 months prior to diagnosis of lung cancer T. Chin, R. Mustafa, A. Roberts (Middlesbrough, United Kingdom)
| |
Importance of further follow up in patients with negative histology from CT guided biopsy A. Sylvan, Y. Liu, T. Houghton, C. Poon, R. Sundar, I. Aziz (Wigan, United Kingdom)
| |
Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions H.R. Kim, K.E. Hwang, H.J. Kim, E.T. Jeong (Iksan, Republic Of Korea)
| |
The elevation serum napsin A in primary lung adenocarcinoma, compared with CEA T. Samukawa, T. Hamada, K. Mizuno, I. Higashimoto, H. Inoue (Kagoshima, Japan)
| |
Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients B. Tulek, H. Koylu, F. Kanat, U. Arslan, F. Ozer (Konya, Turkey)
| |
An unusual diagnostic tool in metastatic bronchogenic carcinoma: Peripheric embolectomy H. Çinarka, A. Gümüs, H. Türüt, A. Kurt, G. Ilhan, A. Yavuz, R. Bedir, U. Sahin (Rize, Turkey)
| |
The antiemetic effects of oral azasetron in lung cancer patients treated with moderately emetogenic chemotherapy: Comparison with intravenous granisetron H. Iihara, J. Endo, M. Yamada, K. Kitaichi, K. Yanase, F. Kamiya, F. Ito, N. Funaguchi, Y. Ohno, S. Minatoguchi, Y. Itoh (Gifu, Japan)
| |
A case of fatal acute liver failure in a 68 year old female treated with erlotinib for lung adenocarcinoma C. Jardin, A. Desplechin, J. Delourme, X. D‘Halluin, A. Scherpereel, J.J. Lafitte, A. Cortot (Lille, France)
| |
Autophagy induction by low dose cisplatin; the role of p53 in autophagy S.H. Yang, K.K. Lee, S.R. Moon (Iksan, Republic Of Korea)
| |
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. 7-year follow-up of a rare clinicopathologic syndrome R.F. Falkenstern-Ge, M. Kimmich, G. Friedel, A. Tannapfel, V. Neumann, M. Kohlhäufl (Gerlingen, Bochum, Germany)
| |
Disappearance of hypoglycemic attacks after resection of solitary fibrous tumors with high expression of insulin-like growth factor II H. Watanabe, K. Akasaka, R. Fukai, T. Terasawa, N. Fueki, K. Fukuda, T. Haga, Y. Kawabata, Y. Ueda, H. Sagara (Koshigaya, Hasuda, Japan)
| |
A temporal effect of EGFR tyrosine kinase inhibitor in lymphoepithelioma-like carcinoma of lung K. Chiu, K. Chiu, T.S. Chen (Taichung, Yilan, Taiwan)
| |
Late lung metastasis of endometrial cancer. Two rare cases of patients with late lung metastasis of primary endometrial cancer 14 and 17 years after initial treatment R.F. Falkenstern-Ge, M. Wohlleber, M. Kimmich, S. Bode-Erdmann, G. Ott, M. Kohlhäufl (Gerlingen, Stuttgart, Germany)
| |
Rare primary chest wall sarcoma: The synovialosarcoma L. Fekih, H. Kamoun, I. Akrout, S. Fenniche, M.L. Megdiche (Ariana, Tunisia)
| |
Lung metastases from colorectal cancer – Surgery, early and late postoperative results V. Stanoev, G. Yankov, M. Plochev, E. Goranov, R. Petkov, D. Petrov (Sofia, Bulgaria)
| |